Ethicon Buying SurgRx

Ethicon Endo-Surgery, a unit of Johnson & Johnson, has agreed to acquire SurgRx Inc., a Redwood City, Calif.-based developer of laparoscopic vessel fusion tools for surgical hemostasis. No financial terms were disclosed. SurgRx has raised around $83 million in total VC funding since 2003, from firms like Alta Partners, New Enterprise Associates, California Technology Ventures, Magnetar Capital Return, Prospect Venture Partners and Trellis Health Ventures.

PRESS RELEASE

Ethicon Endo-Surgery announced today that it has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal